Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20140214 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Phase I Pediatric FMP2.1/AS02A Trial in Mali
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: FMP2.1/AS02A;   Biological: Rabies vaccine (RabAvert)

Indicates status has not been verified in more than two years